SCHEMBL6345103

SCHEMBL6345103

COC(=O)Cc1nc2ccccc2[nH]1

nearest known ligand 0.97

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.97
HSD17B10 Q99714 4/20 0.97
MAPT P10636 4/20 0.97
SMN1; SMN2 Q16637 4/20 0.97
KDM4E B2RXH2 4/20 0.97
POLB P06746 2/20 0.62
TDP1 Q9NUW8 2/20 0.62
MEN1 O00255 1/20 0.62
KMT2A Q03164 1/20 0.62
RAB9A P51151 3/20 0.59
NPC1 O15118 2/20 0.59
LMNA P02545 2/20 0.58
HTT P42858 1/20 0.57
HPGD P15428 1/20 0.57
TSHR P16473 1/20 0.56
DDAH1 O94760 1/20 0.56
ALOX15 P16050 2/20 0.55
CASP1 P29466 2/20 0.55
KDM4A O75164 1/20 0.55
KDM4B O94953 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31529600 0.85 HSD17B10 (1.00) ALDH1A1HSD17B10MAPTSMN1; SMN2KDM4E
SCHEMBL20561440 0.85 MAPT (0.75) ALDH1A1HSD17B10MAPTSMN1; SMN2KDM4E
SCHEMBL1218749 0.85 HSD17B10 (1.00) ALDH1A1HSD17B10MAPTSMN1; SMN2KDM4E
SCHEMBL11450998 0.83 SMN1; SMN2 (0.68) ALDH1A1HSD17B10MAPTSMN1; SMN2KDM4E
SCHEMBL8328337 0.82 ALDH1A1 (0.68) ALDH1A1HSD17B10MAPTSMN1; SMN2KDM4E
SCHEMBL10337354 0.82 ALDH1A1 (0.68) ALDH1A1HSD17B10MAPTSMN1; SMN2KDM4E
SCHEMBL12409534 0.81 ALDH1A1 (0.67) ALDH1A1HSD17B10MAPTSMN1; SMN2KDM4E
SCHEMBL11450997 0.81 ALDH1A1 (0.67) ALDH1A1HSD17B10MAPTSMN1; SMN2KDM4E
SCHEMBL3558037 0.81 KDM4E (0.66) ALDH1A1HSD17B10MAPTSMN1; SMN2KDM4E
SCHEMBL11369264 0.81 KDM4E (0.76) ALDH1A1HSD17B10MAPTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260138071-A1 SULFIDE GAS REMOVAL PROCESS KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-05-21 US disclosed
EP-3364967-B1 FERROPORTIN INHIBITORS VIFOR INT AG (CH) 2026-05-20 EP disclosed
US-20260014197-A1 DRUG DELIVERY SYSTEM IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2026-01-15 US disclosed
US-20260014517-A1 HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-15 US disclosed
US-20260014514-A1 METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-15 US disclosed
US-20260008009-A1 PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-08 US disclosed
US-20260002088-A1 PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2026-01-01 US disclosed
US-20250381514-A1 METHOD FOR REMOVING HYDROGEN SULFIDE FROM SOUR GAS KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-12-18 US disclosed
US-12459862-B2 Cement paste composition KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-11-04 US disclosed
US-12427499-B2 Process for removing hydrogen sulfide from sour gases KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2025-09-30 US disclosed
US-9381196-B2 Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (US) 2016-07-05 US disclosed
WO-2015172123-A1 NOVEL COMPOSITIONS, USES AND METHODS FOR MAKING THEM HADDACH MUSTAPHA (US) 2015-11-12 WO disclosed
WO-2015172123-A1 NOVEL COMPOSITIONS, USES AND METHODS FOR MAKING THEM HADDACH MUSTAPHA (US) 2015-11-12 WO disclosed
US-20150196559-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HYDROXAMIC ACID DERIVATIVES THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (US) 2015-07-16 US disclosed
US-8987468-B2 Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (US) 2015-03-24 US disclosed
US-20120053188-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HYDROXAMIC ACID DERIVATIVES THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE(TGEN (US) 2012-03-01 US disclosed
WO-2007122341-A2 SPECIFIC MONOCATIONIC MONOCHROMOPHORIC HYDRAZONE COMPOUNDS CONTAINING A 2-(BENZ)IMIDAZOLIUM UNIT, THEIR SYNTHESIS, DYEING COMPOSITIONS COMPRISING THEM, METHOD OF DYEING KERATIN FIBRES L'ORÉAL (FR) 2007-11-01 WO disclosed
US-20050250829-A1 Kinase inhibitors TAKEDA SAN DIEGO, INC. 2005-11-10 US disclosed
US-5266320-A Photostability, heat resistance BASF AKTIENGESELLSCHAFT (DE) 1993-11-30 US disclosed
US-4113718-A Basic azo dyes CIBA-GEIGY CORPORATION (US) 1978-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260008009-A1 PROCESS FOR REMOVING HYDROGEN SULFIDE FROM A HYDROCARBON GASEOUS COMPOSITION HMOX2, HMOX1, SCO2 ALDH1A1 3365/4885HSD17B10 2485/4885MAPT 2624/4885
US-20260014517-A1 HYDROGEN SULFIDE REMOVAL METHOD FROM DRILLING MUD COMPOSITION TST, SOD1, SAMM50 ALDH1A1 3428/4885HSD17B10 944/4885MAPT 3068/4885
US-20120053188-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HYDROXAMIC ACID DERIVATIVES HDAC5, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HDAC4 ALDH1A1 863/4885HSD17B10 304/4885MAPT 4212/4885
US-20260002088-A1 PROCESS TO REMOVE HYDROGEN SULFIDE FROM A HYDROCARBON-CONTAINING GAS COMPOSITION SAMM50, SOD1, HNRNPH3 ALDH1A1 3149/4885HSD17B10 2454/4885MAPT 2806/4885
US-20050250829-A1 Kinase inhibitors MAP3K20, MAP3K1, MAP3K2 ALDH1A1 3741/4885HSD17B10 2902/4885MAPT 1135/4885
US-20260138071-A1 SULFIDE GAS REMOVAL PROCESS SAMM50, SRSF1, GTF2F1 ALDH1A1 4587/4885HSD17B10 3462/4885MAPT 2949/4885
US-20260014514-A1 METHOD FOR SCAVENGING HYDROGEN SULFIDE FROM A GASEOUS COMPOSITION IN A STIRRED TANK REACTOR SOD1, MAFG, HMOX2 ALDH1A1 4774/4885HSD17B10 3395/4885MAPT 3303/4885
US-20260014197-A1 DRUG DELIVERY SYSTEM IPO8, SLC39A11, SLC2A8 ALDH1A1 3703/4885HSD17B10 4436/4885MAPT 113/4885
US-20150196559-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HYDROXAMIC ACID DERIVATIVES HDAC5, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HDAC4 ALDH1A1 863/4885HSD17B10 304/4885MAPT 4212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.